These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 22197598

  • 1. [New trends in the treatment of amyloidosis].
    Martínez-Valle F, Gironella-Mesa M, Solans-Laqué R.
    Med Clin (Barc); 2012 May 26; 138(15):667-72. PubMed ID: 22197598
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug Insight: emerging therapies for amyloidosis.
    Gillmore JD, Hawkins PN.
    Nat Clin Pract Nephrol; 2006 May 26; 2(5):263-70. PubMed ID: 16932439
    [Abstract] [Full Text] [Related]

  • 4. Renal amyloidosis: current views on pathogenesis and impact on diagnosis.
    Herrera GA, Teng J, Turbat-Herrera EA.
    Contrib Nephrol; 2011 May 26; 169():232-246. PubMed ID: 21252523
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Amyloidosis--diagnostic difficulties. A case report of localized amyloidosis].
    Maślińska M, Legatowicz-Koprowska M, Przygodzka M.
    Wiad Lek; 2011 May 26; 64(3):202-7. PubMed ID: 22335145
    [Abstract] [Full Text] [Related]

  • 10. Pathophysiology and treatment of systemic amyloidosis.
    Gillmore JD, Hawkins PN.
    Nat Rev Nephrol; 2013 Oct 26; 9(10):574-86. PubMed ID: 23979488
    [Abstract] [Full Text] [Related]

  • 11. [Multisystemic amyloidosis in 2007].
    Grateau G, Valleix S, Callard P.
    Rev Med Interne; 2007 May 26; 28(5):281-3. PubMed ID: 17291633
    [No Abstract] [Full Text] [Related]

  • 12. Amyloidosis.
    Pinney JH, Hawkins PN.
    Ann Clin Biochem; 2012 May 26; 49(Pt 3):229-41. PubMed ID: 22402917
    [Abstract] [Full Text] [Related]

  • 13. [Characterization of amyloidosis].
    Yazaki M, Ikeda S.
    Brain Nerve; 2014 Jul 26; 66(7):723-30. PubMed ID: 24998817
    [Abstract] [Full Text] [Related]

  • 14. Advances in the treatment of amyloidosis.
    Rajkumar SV, Gertz MA.
    N Engl J Med; 2007 Jun 07; 356(23):2413-5. PubMed ID: 17554124
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Systemic AA amyloidosis induced by benign neoplasms].
    Bestard Matamoros O, Poveda Monje R, Ibernon Vilaró M, Carrera Plans M, Grinyó Boira JM.
    Nefrologia; 2008 Jun 07; 28(1):93-8. PubMed ID: 18336138
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel pharmacological strategies in amyloidosis.
    Lachmann HJ, Hawkins PN.
    Nephron Clin Pract; 2003 Jun 07; 94(4):c85-8. PubMed ID: 12972717
    [Abstract] [Full Text] [Related]

  • 19. Clinical aspects of systemic amyloid diseases.
    Obici L, Perfetti V, Palladini G, Moratti R, Merlini G.
    Biochim Biophys Acta; 2005 Nov 10; 1753(1):11-22. PubMed ID: 16198646
    [Abstract] [Full Text] [Related]

  • 20. The Pathology of Amyloidosis in Classification: A Review.
    Picken MM.
    Acta Haematol; 2020 Nov 10; 143(4):322-334. PubMed ID: 32392555
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.